Delivery Order SPE2DB22D2214-SPE2DB25FS5DN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,881.99 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply agreement running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a contract ceiling value of $50,372.45 and a firm fixed-price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets in quantities of 90 units, with a contract ceiling value of $2,211.60. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,665.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The award, issued on June 27, 2025, with a completion date of June 30, 2025, represents a non-set-aside competitive procurement. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $14,019.04 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 16, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 100 mg tablets (90-count) at a ceiling value of $1,066.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,641.20 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed price contract type. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Januvia 100mg tablets (90-count units) under a firm fixed-price contract valued at $10,040.31. This non-set-aside delivery order is scheduled for completion by October 22, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5DNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Januvia 100 mg tablets (1,000 units) with a contract value of $6,720.70. This is a firm fixed-price delivery order with an ultimate completion date of May 28, 2025, and represents a non-set-aside award made through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical support vehicle for military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's portfolio with the DLA encompasses a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Januvia order fulfills the diabetes medication needs within the broader pharmaceutical supply chain supporting the Defense Health Agency and other federal healthcare systems. This delivery order exemplifies the company's ongoing role as a primary supplier under the DLA's pharmaceutical contracting strategy, which includes plans for regional prime vendor contracts involving multiple award recipients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 5/27/25 |